NEW YORK (GenomeWeb News) – California consumer genomics company 23andMe has confirmed that it has laid off some of its workers as part of an effort to maintain competitiveness and respond to a weak economy, the company said.

The firm did not say how many positions have been cut or what parts of the company were hit by the layoffs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.